158 related articles for article (PubMed ID: 22195531)
1. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review.
Cruz DN; Goh CY; Marenzi G; Corradi V; Ronco C; Perazella MA
Am J Med; 2012 Jan; 125(1):66-78.e3. PubMed ID: 22195531
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review.
Cruz DN; Perazella MA; Bellomo R; Corradi V; de Cal M; Kuang D; Ocampo C; Nalesso F; Ronco C
Am J Kidney Dis; 2006 Sep; 48(3):361-71. PubMed ID: 16931209
[TBL] [Abstract][Full Text] [Related]
3. Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
Song K; Jiang S; Shi Y; Shen H; Shi X; Jing D
Am J Nephrol; 2010; 32(5):497-504. PubMed ID: 20975263
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.
Kurnik BR; Allgren RL; Genter FC; Solomon RJ; Bates ER; Weisberg LS
Am J Kidney Dis; 1998 Apr; 31(4):674-80. PubMed ID: 9531185
[TBL] [Abstract][Full Text] [Related]
5. The role of extracorporeal blood purification therapies in the prevention of radiocontrast-induced nephropathy.
Cruz DN; Perazella MA; Ronco C
Int J Artif Organs; 2008 Jun; 31(6):515-24. PubMed ID: 18609504
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
Duong MH; MacKenzie TA; Malenka DJ
Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Cho HS; Seo JW; Kang Y; Bae EJ; Kim HJ; Chang SH; Park DJ
Clin Exp Nephrol; 2011 Oct; 15(5):714-719. PubMed ID: 21695415
[TBL] [Abstract][Full Text] [Related]
8. Radiocontrast-induced nephropathy: an update.
Perazella MA
Minerva Urol Nefrol; 2009 Sep; 61(3):215-33. PubMed ID: 19773724
[TBL] [Abstract][Full Text] [Related]
9. Validation of a predictive risk score for radiocontrast-induced nephropathy following percutaneous coronary intervention.
Skelding KA; Best PJ; Bartholomew BA; Lennon RJ; O'Neill WW; Rihal CS
J Invasive Cardiol; 2007 May; 19(5):229-33. PubMed ID: 17476039
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
Merkle M; Sauter M; Argirov M; Wörnle M
Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272
[TBL] [Abstract][Full Text] [Related]
11. Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure.
Margulies KB; McKinley LJ; Cavero PG; Burnett JC
Kidney Int; 1990 Dec; 38(6):1101-8. PubMed ID: 2150085
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
[TBL] [Abstract][Full Text] [Related]
13. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.
Bartholomew BA; Harjai KJ; Dukkipati S; Boura JA; Yerkey MW; Glazier S; Grines CL; O'Neill WW
Am J Cardiol; 2004 Jun; 93(12):1515-9. PubMed ID: 15194023
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Zhang L; Zhang L; Lu Y; Wu B; Zhang S; Jiang H; Ge J; Chen H
Int J Clin Pract; 2011 May; 65(5):624-30. PubMed ID: 21489086
[TBL] [Abstract][Full Text] [Related]
15. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials.
Alonso A; Lau J; Jaber BL; Weintraub A; Sarnak MJ
Am J Kidney Dis; 2004 Jan; 43(1):1-9. PubMed ID: 14712421
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome in ICU patients with acute kidney injury treated with renal replacement therapy: a prospective cohort study.
De Corte W; Dhondt A; Vanholder R; De Waele J; Decruyenaere J; Sergoyne V; Vanhalst J; Claus S; Hoste EA
Crit Care; 2016 Aug; 20(1):256. PubMed ID: 27520553
[TBL] [Abstract][Full Text] [Related]
17. Radiocontrast-induced nephropathy: current status and future prospects.
Margulies K; Schirger J; Burnett J
Int Angiol; 1992; 11(1):20-5. PubMed ID: 1387889
[TBL] [Abstract][Full Text] [Related]
18. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans.
Weisberg LS; Kurnik PB; Kurnik BR
Ren Fail; 1993; 15(1):61-8. PubMed ID: 8441838
[TBL] [Abstract][Full Text] [Related]
19. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis.
Seabra VF; Balk EM; Liangos O; Sosa MA; Cendoroglo M; Jaber BL
Am J Kidney Dis; 2008 Aug; 52(2):272-84. PubMed ID: 18562058
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points.
Hoffmann U; Banas B; Fischereder M; Krämer BK
Kidney Blood Press Res; 2004; 27(3):161-6. PubMed ID: 15256811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
